Department of Respiratory Diseases, Ghent University Hospital.
Department of Respiratory Diseases, University Hospitals Leuven, Belgium.
Ann Oncol. 2011 Jan;22(1):127-131. doi: 10.1093/annonc/mdq311. Epub 2010 Jul 5.
extrathoracic malignancies metastasize to the mediastinum and/or pulmonary hilum. Mediastinoscopy and thoracoscopy are standard to obtain tissue proof of metastatic spread but are invasive. Endobronchial ultrasound with real-time-guided transbronchial fine-needle aspiration (EBUS-TBNA) is a minimally invasive alternative for surgical staging of lung cancer.
we analysed the test characteristics of EBUS-TBNA in consecutive patients with a suspicion of mediastinal or hilar metastases of various extrathoracic malignancies.
ninety-two patients with concurrent (n = 33) or previously diagnosed and treated (n = 59) extrathoracic malignancies were evaluated. EBUS-TBNA detected mediastinal or hilar metastatic spread in 52 patients (57%) [metastasis of extrathoracic tumour in 40 (44%) and second malignancies (lung cancer) in 12 (13%)]. Subsequent surgical staging showed malignancy in another nine patients. With EBUS-TBNA, an alternate diagnosis was found in four. Sensitivity and negative predictive value for mediastinal or hilar metastatic spread were 85% [95% confidence interval (CI) 73-93] and 76% (95% CI 59-88). EBUS-TBNA prevented an invasive surgical procedure in 61% of the patients. One patient had a respiratory arrest during EBUS-TBNA; abortion lead to full recovery without further intervention.
EBUS-TBNA is a minimally invasive method for M staging of patients with extrathoracic malignancies to confirm mediastinal or hilar spread. EBUS-TBNA therefore may qualify as an alternative for surgical staging.
胸腔外恶性肿瘤转移至纵隔和/或肺门。纵隔镜检查和胸腔镜检查是获得转移性播散组织学证据的标准方法,但具有侵袭性。支气管内超声引导下经支气管针吸活检术(EBUS-TBNA)是一种微创替代方法,可用于肺癌的外科分期。
我们分析了连续怀疑纵隔或肺门有各种胸腔外恶性肿瘤转移的患者中 EBUS-TBNA 的检测特征。
92 例同时(n=33)或先前诊断和治疗(n=59)的胸腔外恶性肿瘤患者接受了评估。EBUS-TBNA 在 52 例患者(57%)中检测到纵隔或肺门转移性播散[胸腔外肿瘤转移 40 例(44%)和第二恶性肿瘤(肺癌)12 例(13%)]。随后的外科分期在另外 9 例患者中发现了恶性肿瘤。通过 EBUS-TBNA,在 4 例中发现了另一种诊断。纵隔或肺门转移性播散的敏感性和阴性预测值分别为 85%(95%置信区间[CI]73-93%)和 76%(95%CI 59-88%)。EBUS-TBNA 使 61%的患者避免了侵袭性手术。1 例患者在 EBUS-TBNA 期间出现呼吸骤停;中止操作导致完全恢复,无需进一步干预。
EBUS-TBNA 是一种微创方法,可用于胸腔外恶性肿瘤患者的 M 分期,以确认纵隔或肺门的播散。因此,EBUS-TBNA 可能有资格替代外科分期。